Женское здоровье. Без стыда и глупостей
Часть 38 из 46 Информация о книге
Для доступа к библиотеке пройдите авторизацию
132
73. Chow EP, Howden BP, Walker S, et al. Antiseptic mouthwash against pharyngeal Neisseria gonorrhoeae: a randomized controlled trial and an in vitro study. Sex Transm Infect 2017; 93(2): 88–93.
133
22. Cancer Research UK. Cancer mortality statistics. 2017. http://www.cancerresearchuk.org/health-professional/cancer-statistics/mortality/common-cancers-compared.
134
74. Giannaki M, Kakourou T, Theodoridou M, et al. Human papillomavirus (HPV) genotyping of cutaneous warts in Greek children. Pediatr Dermatol 2013; 30(6): 730–5.
135
75. Davies S. The cervical smear test: does timing have an effect on sample adequacy? Cytopathology 2006; 17(4): 182–6.
136
79. Mouchet J, Salvo F, Raschi E, et al. Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis. Pharmacol Res 2018.
137
77. Kyrgiou M, Mitra A, Arbyn M, et al. Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis. BMJ 2014; 349: g6192.
138
78. Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015; 372(8): 711–23.
139
79. Mouchet J, Salvo F, Raschi E, et al. Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis. Pharmacol Res 2018.
140
80. Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency. Assessment report. Review under Article 20 of Regulation (EC) № 726/2004, human papillomavirus (HPV) vaccines. EMA/762033/2015., 2015.
141
81. Drolet M, Benard E, Boily MC, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2015; 15(5): 565–80.
142
83. Kang WD, Choi HS, Kim SM. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol Oncol 2013; 130(2):264–8.
143
83. Kang WD, Choi HS, Kim SM. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol Oncol 2013; 130(2):264–8.
144
84. Garcia-Closas R, Castellsague X, Bosch X, Gonzalez CA. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer 2005; 117(4): 629–37.
145
1. Barnhart KT, Schreiber CA. Return to fertility following discontinuation of oral contraceptives. Fertil Steril 2009; 91(3): 659–63.
73. Chow EP, Howden BP, Walker S, et al. Antiseptic mouthwash against pharyngeal Neisseria gonorrhoeae: a randomized controlled trial and an in vitro study. Sex Transm Infect 2017; 93(2): 88–93.
133
22. Cancer Research UK. Cancer mortality statistics. 2017. http://www.cancerresearchuk.org/health-professional/cancer-statistics/mortality/common-cancers-compared.
134
74. Giannaki M, Kakourou T, Theodoridou M, et al. Human papillomavirus (HPV) genotyping of cutaneous warts in Greek children. Pediatr Dermatol 2013; 30(6): 730–5.
135
75. Davies S. The cervical smear test: does timing have an effect on sample adequacy? Cytopathology 2006; 17(4): 182–6.
136
79. Mouchet J, Salvo F, Raschi E, et al. Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis. Pharmacol Res 2018.
137
77. Kyrgiou M, Mitra A, Arbyn M, et al. Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis. BMJ 2014; 349: g6192.
138
78. Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015; 372(8): 711–23.
139
79. Mouchet J, Salvo F, Raschi E, et al. Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis. Pharmacol Res 2018.
140
80. Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency. Assessment report. Review under Article 20 of Regulation (EC) № 726/2004, human papillomavirus (HPV) vaccines. EMA/762033/2015., 2015.
141
81. Drolet M, Benard E, Boily MC, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2015; 15(5): 565–80.
142
83. Kang WD, Choi HS, Kim SM. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol Oncol 2013; 130(2):264–8.
143
83. Kang WD, Choi HS, Kim SM. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol Oncol 2013; 130(2):264–8.
144
84. Garcia-Closas R, Castellsague X, Bosch X, Gonzalez CA. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer 2005; 117(4): 629–37.
145
1. Barnhart KT, Schreiber CA. Return to fertility following discontinuation of oral contraceptives. Fertil Steril 2009; 91(3): 659–63.